Inotrope, Evaluation and Research (INTERPRET) Patient Registry Program
The INTERPRET Inotrope Evaluation and Research Patient Registry is a longitudinal, observational study designed to look at the demographics and outcomes of heart failure patients on inotropic therapy administered in the home or infusion suite setting. The data gathered in this registry will provide information on how a patient's quality of life and symptoms change over time while on inotrope therapy, and help healthcare providers to have a better understanding of the benefits and risks associated with bridge-to-treatment and palliative care.
• Patient must be prescribed inotropic treatment (milrinone, dobutamine or dopamine)
• Patient must be referred to Coram for this treatment in an alternate site of care, either home or infusion suite
• Patient must be willing to receive care and comply with the teaching and training necessary to administer treatment
• Patient is age 18 or over